Frontiers in Pharmacology | Inflammation Pharmacology

Correction

Accepted on 12 Aug 2025

Correction: α-Mangostin alleviated inflammation in rats with adjuvant-induced arthritis by disrupting adipocytes-mediated metabolism-immune feedback

in Inflammation Pharmacology

Ying-Hao Hu
Jun Han
Lin Wang
Chao Shi
Yan Li
Opeyemi Joshua Olatunji
Xiu Wang
Jian Zuo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1671368

Systematic Review

Published on 11 Aug 2025

Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis

in Inflammation Pharmacology

Ziyu Qi
Yan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1576553

581 views

Clinical Trial

Published on 07 Aug 2025

The anti-inflammatory and antioxidant effects of astaxanthin as an adjunctive therapy in community-acquired pneumonia: a randomized controlled trial

in Inflammation Pharmacology

Fatma Makram Youssef
Hayam Ateyya
Amir Eskander Hanna Samy
Eman Mohamed Elmokadem

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1621308

650 views

Review

Published on 06 Aug 2025

Exploring dupilumab for asthma: from mechanistic insights to clinical outcomes, safety, and cost-effectiveness

in Inflammation Pharmacology

Omar Z. Ameer
Ghaith K. Mansour
Raghad S. Al-Amoudi
Fahmi M. Abu‐Owaimer

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1631321

1,132 views

Review

Published on 06 Aug 2025

Research progress in treatment of rheumatoid arthritis with Sinomenine and related formulations based on different administration routes

in Inflammation Pharmacology

Wenya Wang
Zihui Wang
Aixia Ling
Chunyan Zhang
Mei Lv
Lufen Huang
Yanlian Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613679

666 views

Original Research

Accepted on 04 Aug 2025

Opposing Profiles of Netrin-1 and Adiponectin in Metabolic Inflammation and Insulin Resistance

in Inflammation Pharmacology

Maria Guadalupe Ramos-Zavala
Jesus Jonathan García-Galindo
Alberto Beltrán-Ramírez
Luis Ricardo Balleza-Alejandri
Emiliano Peña-Durán
Alfredo Huerta Huerta
Edy David Rubio Arellano
Luis Daniel López-Murillo
Sara Pascoe-Gonzalez
Tannia Isabel Campos Bayardo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632956

164 views

Original Research

Published on 25 Jul 2025

Unique compound with anti-allergic action: inhibition of Lyn kinase activity by KIRA6

in Inflammation Pharmacology

Goshi Matsushima
Yuri Matsui
Hanano Okamoto
Nagisa Umeda
Mai Kakimoto
Megumi Mino
Tadashi Nakagawa
Kaori Ishii
Yoshimi Matsuo
Daiki Matsubara

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1625798

661 views

Review

Accepted on 24 Jul 2025

Apremilast Treatment of Immune-mediated Inflammatory Skin Diseases: A Narrative Review

in Inflammation Pharmacology

Xiaoqian Liang
Jiecheng Zheng
Xueyi Huang
Min Tan
Jia Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1633426

190 views

Original Research

Published on 23 Jul 2025

Degradation of IRAK4 for the treatment of lipopolysaccharide-induced acute lung injury in mice

in Inflammation Pharmacology

Bijun Ye
Shiyan Chen
Xiaohao Huang
Yinhong Qiu
Ruixiang Luo
Lulu Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1609923

826 views

Original Research

Published on 21 Jul 2025

Role of homovanillic acid esters in the regulation of skin inflammatory pathways and their effect on tight junction protein expression

in Inflammation Pharmacology

Maria Fernanda Cervantes Recalde
Elena Zoe Bogensperger
Joachim Hans
Dominik Stuhlmann
Veronika Somoza
Barbara Lieder

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1629941

508 views

Systematic Review

Accepted on 15 Jul 2025

Efficacy and Safety of Topical vs. Oral Calcium Channel Blockers for Chronic Anal Fissures: A Systematic Review and Meta-Analysis

in Inflammation Pharmacology

Li Tianshuo
Pengfei Ye
Xinli He
Chen Li
Lanlan Xi
Zuowu Xi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1642347

198 views

Correction

Published on 14 Jul 2025

Correction: Berberine ameliorates subarachnoid hemorrhage injury via induction of Sirtuin 1 and inhibiting HMGB1/Nf-κB pathway

in Inflammation Pharmacology

Xiang-Hua Zhang
Lei Peng
Jing Zhang
Yi-Peng Dong
Cheng-Jun Wang
Cang Liu
Da-Yong Xia
Xiang-Sheng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540873

477 views

Original Research

Published on 11 Jul 2025

Lumefantrine ameliorates DSS-induced colitis by targeting FLI-1 to suppress NF-κB signaling

in Inflammation Pharmacology

Ji Yang
Peng Guo
Hongtao Luo
Xin Tang
Wei Liu
Xiaolin Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1614978

894 views

Original Research

Published on 07 Jul 2025

Antagonizing IL-6 receptor restores pancreatic tissue resident NK cells activation and ameliorates pancreatic injury in the mouse model of MASH

in Inflammation Pharmacology

Johnny Amer
Diana Abu Arra
Ahmad Salhab
Faris Kayed
Muneer Maali
Raghad Shweiki
Mustafa Ghanim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611637

1,489 views

Original Research

Published on 02 Jul 2025

Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms

in Inflammation Pharmacology

Shuzhen Mao
Jiahui Huang
Junyan Li
Fang Sun
Qilian Zhang
Qing Cheng
Wei Zeng
Dongya Lei
Shiyan Wang
Jing Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551843

1,925 views

Systematic Review

Published on 01 Jul 2025

Immunomodulatory effects of ulinastatin combined with continuous blood purification in sepsis: a systematic review and meta-analysis

in Inflammation Pharmacology

Hui Gao
Zhiqiang Tang
Shucheng Zhao
Yuanjun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591470

1,000 views